Safety in immunotherapy with dust mite allergens in asthma and allergic rhinitis

被引：0
|
作者：
Celio Murillo, R. [1 ]
Laurrabaquio Miranda, A. M. [2 ]
Abou Kahir, F. [3 ]
Tinoco Moran, I. O. [4 ]
Rodriguez Santos, O. [5 ]
Cuevas Castillejos, H. U. [6 ]
Cruz Suarez, M. A. [7 ]
机构：
[1] Unidad Med Integral, Tehuacan, Mexico
[2] Hosp Reg Lic Adolfo Lopez Mateos Mexico, Mexico City, DF, Mexico
[3] Clin Santa Rosa Tigre Estado Anzoategui Venezuela, El Tigre, Venezuela
[4] Clin Torre Med Ciudad Machala, Machala, Ecuador
[5] Policlin Univ Docente Previsora Camaguey Cuba, Camaguey, Cuba
[6] Hosp Angeles del Pedregal, Mexico City, DF, Mexico
[7] Ctr Med Especialidades Sa Cv Cd Juarez Chihuahua, Ciudad Juarez, Mexico
来源：
ALLERGY | 2013年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：585 / 585
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of immunotherapy with mite extracts in allergic rhinitis and asthma
    Celio Murillo, R.
    Rodriguez Santos, O.
    Cruz Suarez, M. A.
    Laurrabaquio Miranda, A. M.
    Cruz Marmolejo, M. A.
    [J]. ALLERGY, 2015, 70 : 454 - 454
  • [2] Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
    Trebuchon, Florence
    Lheritier-Barrand, Michele
    David, Marie
    Demoly, Pascal
    [J]. CLINICAL AND TRANSLATIONAL ALLERGY, 2014, 4
  • [3] House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis
    Feng, Mulin
    Zeng, Xiaohui
    Li, Jing
    [J]. JOURNAL OF THORACIC DISEASE, 2019, 11 (08) : 3616 - 3625
  • [4] Safety of Modified Dust Mite Subcutaneous Immunotherapy in Severe Allergic Asthma
    Gonzalez, Ruperto
    Poza, Paloma
    Matheu, Victor
    Sanchez-Machin, Inmaculada
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB205 - AB205
  • [5] Dust mite component Analysis: Identifying key allergens components for effective immunotherapy in allergic rhinitis
    Huang, Jingyu
    Xiang, Rong
    Tan, Lu
    Deng, Yuqin
    Tao, Zezhang
    Zhang, Wei
    Xu, Yu
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [6] Efficacy and safety of 2-year subcutaneous immunotherapy with house dust mite extract for allergic rhinitis and asthma
    Tu, Y.
    Shi, L.
    Zhi, L.
    Zhao, L.
    Jin, P.
    Zi, X.
    Li, A.
    Jin, Y.
    [J]. ALLERGY, 2016, 71 : 336 - 336
  • [7] SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms
    Mosbech, Holger
    Canonica, G. Walter
    Backer, Vibeke
    de Blay, Frederic
    Klimek, Ludger
    Broge, Louise
    Ljorring, Christian
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 114 (02) : 134 - U183
  • [8] House dust mite sublingual immunotherapy in allergic rhinitis
    Cho, Sung-Woo
    Han, Doo Hee
    Kim, Jeong-Whun
    Kim, Dong-Young
    Rhee, Chae-Seo
    [J]. IMMUNOTHERAPY, 2018, 10 (07) : 567 - 578
  • [9] Clinical efficacy and safety of combined house dust mite subcutaneous immunotherapy and omalizumab in five cases of allergic rhinitis and asthma
    Kathuria, P. C.
    Rai, Manisha
    [J]. INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2021, 12 (03) : 175 - 178
  • [10] Effect of house dust mite sublingual immunotherapy on airway inflammation and remodeling in allergic asthma with rhinitis
    Hoshino, Makoto
    Akitsu, Kenta
    Kubota, Kengo
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345